NEJM: Measles 2025
A recent article in the New England Journal of Medicine (NEJM) reviews the current epidemiology of measles and addresses recommendations for prevention.
The authors note that the recommended age for the first dose of measles-containing vaccine depends on the waning of maternal antibodies and the risk of measles exposure. The review highlights immunity gaps in young infants, and examines the utility of an early or additional vaccine dose for more effective protection.
Read the article in full here: Do LAH, Mulholland K. Measles 2025. N Engl J Med. Published online June 25, 2025. doi:10.1056/NEJMra2504516
WHO: Measles case data for the Western Pacific Region
TGA: Correct administration of RSV vaccine and antibody products
这 治疗用品管理局 (TGA) has recently published a safety update with advice on how to avoid errors when administering RSV vaccine and antibody products.
The advice has been published in response to reports of administration errors. The article reminds prescribers and providers that each product is indicated for different patient groups, includes a summary of RSV products and administration errors, and provides advice for preventing errors.
MVEC recently published an error alert on RSV products, which outlines RSV errors reported in Victoria. This alert summarises error prevention, and procedures to follow in the event of an error.
Read the TGA article in full
MVEC：呼吸道合胞病毒（RSV）
MVEC: Vaccine errors: prevention, management and open disclosure (eLearning course)
MVEC: Flyers for ‘Abrysvo for pregnant people’ flyer
New MVEC website section: Flyers
We are excited to share that you can now access some of MVEC’s most popular infographic resources on our website. MVEC regularly posts vaccine education on social media, including visual content that was previously only viewable on Instagram @mvecau.
In our new Flyers section of the MVEC Media library, download A4 PDF versions of popular graphics.
NIP: Change to measles-containing vaccine supply
From 1 July 2025, there are new arrangements for the supply of measles-containing vaccines under the 国家免疫计划（NIP）. Whereas previously both GSK and CLS supplied these vaccines, now only GSK will supply them.
Vaccine providers cannot place new orders for CSL’s M-M-R II (MMR) or Varivax (varicella). But existing stock should still be used until it either expires or runs out.
Providers can now only order GSK’s Priorix (MMR), Priorix-Tetra (MMR) and Varilrix (varicella).
NCIRS: Australian Vaccinology Course
Applications for the upcoming National Centre for Immunisation Research and Surveillance Australia (NCIRS) vaccinology course will close on Sunday 29 June 2025. The three-day in-person course will be held in Sydney from 28–30 August, with options to attend days 1 and 2, day 3 only, or all three days.
Learn more and apply on the NCIRS website.
JAMA: Advisory Committee on Immunization Practices at a Crossroads
Following their dismissal earlier this month from Advisory Committee on Immunization Practices (ACIP), 17 former members have authored an article published in the Journal of the American Medical Association (JAMA). The article outlines the history, function and importance of ACIP and highlights the authors' concern for the impact on US immunisation policy.
ACIP is the national immunisation technical advisory group (NITAG) for the United States – the equivalent of Australia’s ATAGI. ACIP has been an internationally recognised leading NITAG, holding three regular meetings each year in which the committee reviews scientific data and votes on US vaccine recommendations. These meetings have been open to the public via live webcast, and materials, including all presentation slides, have been made available for download following the meetings.
Find more information about NITAGs on the Global NITAG Network’s (GNN) website.
Immunisation Coalition: 2025 RSV Update webinar
这 Immunisation Coalition will host its RSV webinar on 9 July 2025. Featuring A/Prof Nusrat Homaira with Dr Andrew Bird moderating, the webinar will cover RSV epidemiology, disease burden and an update on the maternal RSV vaccination and monoclonal antibody.
日期： 9 July 2025
时间： 6:00–7:00 pm (AEST)
Learn more and register on the Immunisation Coalition event page.
INSIG: Biennial Immunisation Conference
On 17 October, INSIG Inc (the Immunisation Nurses Special Interest Group) will hold a full-day event exploring the latest in immunisation practice, policy and innovation. Early Bird pricing is available until 1 August 2025.
Date: Friday 17 October 2025
Time: 8:45 am – 4:14 pm (AEDT)
Venue: ANMF (Vic Branch) in Melbourne
AHPC statement on measles
With the recent increase in measles cases occurring internationally and across Australia, the Australian Health Protection Committee (AHPC) has highlighted 4 key priority areas to focus efforts:
- on-time vaccination for children
- catch-up vaccination for children and adults
- vaccination for travellers (including an additional measles vaccination for those aged 6–11 months travelling to countries where outbreaks are occurring)
- nationally consistent information for healthcare providers and the public.
Measles is highly infectious, causing severe disease and complications (including otitis media, pneumonia, encephalitis, and can be fatal). Between 1 January and 27 May 2025, 77 people have been diagnosed with measles in Australia, most were people aged 20 to 49 years who were either unvaccinated or unsure of vaccine status and had travelled overseas.
Vaccination is very effective in preventing disease; receiving 2 doses of a measles-containing vaccines will protect 99% of people.
For more information, read the full AHPC statement.
MVEC：麻疹
RSV Awareness Week: 1–7 June 2025
It is national RSV Awareness Week. Led by Immunisation Foundation Australia, this annual campaign aims to raise awareness of RSV and its impact, as well as champion RSV protection for infants and older adults.
Visit the RSV Awareness Week website for RSV resources and campaign assets to promote RSV protection. You can also learn more about RSV at MVEC：呼吸道合胞病毒（RSV）.